Osteoarthritis (OA) is a rheumatic disease and its pathogenesis involves the dysregulation of noncoding RNAs. Therefore, the regulatory mechanism of circular RNA MELK (circMELK) was specified in this work. OA human cartilage tissue was collected, and circMELK, miR‐497‐5p, and myeloid differentiation factor 88 (MYD88) expression were examined. Human chondrocytes were stimulated with interleukin‐ (IL‐) 1β and interfered with vectors altering circMELK, miR‐497‐5p, and MyD88 expression to observe their effects on cell viability, cell cycle and apoptosis, autophagy, and inflammation. The binding relationship between RNAs was verified. The data presented that OA cartilage tissues presented raised circMELK and MYD88 and inhibited miR‐497‐5p expression. IL‐1β suppressed cell viability, prevented cell cycle, and induced apoptosis, autophagy, and inflammation of chondrocytes. Functionally, IL‐1β‐induced changes of chondrocytes could be attenuated by suppressing circMELK or overexpressing miR‐497‐5p. circMELK acted as a sponge of miR‐497‐5p while miR‐497‐5p was a regulator of MYD88. MYD88 restricted the effect of overexpressing miR‐497‐5p on IL‐1β‐stimulated chondrocytes. MYD88 triggered nuclear factor‐kappaB (NF‐κB) pathway activation. Shortly, CircMELK promotes chondrocyte apoptosis and inhibits autophagy in OA by regulating MYD88/NF‐κB signaling axis through miR‐497‐5p. Our study proposes a new molecular mechanism for the development of OA.
Early intramedullary nailing (IMN) within the first 24 h for multiply injured patients with femoral fracture and concomitant thoracic trauma is controversial. Previously published studies have been limited in size and their outcomes have been inconclusive. A meta-analysis was conducted to evaluate the available data in order to guide care and help improve the outcomes for these patients. We searched the literature up to December 2011 in the main medical search engines and identified 6 retrospective cohort studies that explored the safety of early IMN in patients with both femoral fracture and chest injury. Our primary outcome was the rates of pulmonary complication (pneumonia, adult respiratory distress syndrome, fat embolism syndrome), multiple organ failure (MOF) and mortality. We found no statistically significant difference in the rate of pulmonary complications, MOF or mortality in the patients treated with early IMN. Early IMN for femoral fractures does not increase the mortality and morbidity in chest-injured patients in the studies analyzed.